Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Agilent and University of Queensland ally on oral cancer research

Agilent and University of Queensland ally on oral cancer research

27th November 2013

Agilent Technologies has announced a new oral cancer collaboration with the University of Queensland Centre for Clinical Research.

The project will see the two organisations allying to increase understanding of the genomic differences between young and older patients with oral cancer, as well as studying ways of identifying progressive and non-progressive potentially malignant lesions.

Staff from Agilent will work alongside a University of Queensland team headed by associate professor Camile Farah, head of the facility's oral oncology research programme. Patient data will be selectively enriched using Agilent's SureSelect target enrichment system, with DNA sequencing to be carried out using the the SOLiD5500 from Life Technologies.

Agilent's Dr Russell McInnes, general manager for genomics solutions for south Asia Pacific and Korea, said: "Working with Professor Farah, we will enable greater understanding of the genetic changes that characterise oral cancers."

This comes after the company announced a neurometabolomics research collaboration with the Daegu Gyeongbuk Institute of Science and Technology in South Korea last month.ADNFCR-8000103-ID-801665849-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.